Blood hyperviscosity with reduced skin blood flow in scleroderma.
about
A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenonPlasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes.A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.Raynaud's syndromeSystemic sclerosis: a collagen or microvascular disease?Successful long-term (22 year) treatment of limited scleroderma using therapeutic plasma exchange: Is blood rheology the key?Haemorrheological response to plasma exchange in Raynaud's syndrome.Systemic sclerosis--a microvascular disorder?
P2860
Q33555611-69A1BB80-A976-45D3-8A41-AF934171ED09Q33555933-05821300-EE4A-4547-9778-A9A78F828728Q33563316-BB708FB8-7D38-4894-B682-F9B1B07A9D5BQ35168169-1EAF110B-9204-4F1F-8378-8C47CE7753B5Q41984976-41D82A38-5A3F-4874-BD54-AA4FE0E0DFE5Q46519818-31F7E97A-FE63-4046-9869-477CE91C2EAEQ48577234-C98B9070-A3FF-4F75-A943-C66F9074692EQ55447984-5833824D-45BC-4682-AE50-63C722A24B58
P2860
Blood hyperviscosity with reduced skin blood flow in scleroderma.
description
1977 nî lūn-bûn
@nan
1977 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@ast
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@en
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@nl
type
label
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@ast
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@en
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@nl
prefLabel
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@ast
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@en
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@nl
P2093
P2860
P356
P1476
Blood hyperviscosity with reduced skin blood flow in scleroderma.
@en
P2093
P2860
P304
P356
10.1136/ARD.36.6.569
P407
P577
1977-12-01T00:00:00Z